ARCTURUS THERAPEUTICS HOLDINGS INC. Prepaid Expense, Current
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Prepaid Expense, Current of $1.34 million as of 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2020-05-08
- 2020-03-31: Prepaid Expense, Current $1.34M.
- 2019-12-31: Prepaid Expense, Current $720.00K.
- 2019-09-30: Prepaid Expense, Current $2.58M.
- 2019-06-30: Prepaid Expense, Current $1.66M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2020-03-31 | $1.34M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $720.00K 10-Q · filed 2020-05-08 |
| 2019-09-30 | $2.58M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.66M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $546.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |